VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 97 of Oncotarget features Figure 4, "Representative examples of FR expression detected on canine kidney," by Szigetvari, et al.
|
|
Table of Contents
Editorial
|
| Premetastatic niche and tumorrelated leukocytosis: a close relationship that cannot be ignored in uterine cancer patients |
|
https://doi.org/10.18632/oncotarget.26425
|
| 36889-36890 |
Research Perspectives
|
| Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after Helicobacter pylori eradication |
|
https://doi.org/10.18632/oncotarget.26382
|
| 36891-36893 |
Research Papers
|
| Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib |
|
https://doi.org/10.18632/oncotarget.26380
|
| 36894-36905 |
|
| Evaluation of premir34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A casecontrol study |
|
https://doi.org/10.18632/oncotarget.26385
|
| 36906-36913 |
|
| TRAIL stabilization and cancer cell sensitization to its proapoptotic activity achieved through genetic fusion with arginine deiminase |
|
https://doi.org/10.18632/oncotarget.26398
|
| 36914-36928 |
|
| Genomic loss of HLA alleles may affect the clinical outcome in lowrisk myelodysplastic syndrome patients |
|
https://doi.org/10.18632/oncotarget.26405
|
| 36929-36944 |
|
| Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatmentnaïve and vemurafenibresistant melanomas |
|
https://doi.org/10.18632/oncotarget.26421
|
| 36945-36965 |
|
| Time to progression to castrationresistant prostate cancer after commencing combined androgen blockade for advanced hormonesensitive prostate cancer |
|
https://doi.org/10.18632/oncotarget.26426
|
| 36966-36974 |
|
| Insight into the PTEN – p85α interaction and lipid binding properties of the p85α BH domain |
|
https://doi.org/10.18632/oncotarget.26432
|
| 36975-36992 |
|
| CD39+ regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function |
|
https://doi.org/10.18632/oncotarget.26435
|
| 36993-37007 |
|
| The highsensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer |
|
https://doi.org/10.18632/oncotarget.26438
|
| 37008-37016 |
|
| Secondline treatment after sunitinib therapy in patients with renal cell carcinoma: a comparison of axitinib and mammalian target of rapamycin inhibitors |
|
https://doi.org/10.18632/oncotarget.26439
|
| 37017-37025 |
|
| NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.26443
|
| 37026-37041 |
|
| Phase I/II clinical trial of the targeted chemotherapeutic drug folatetubulysin in dogs with naturallyoccurring invasive urothelial carcinoma |
|
https://doi.org/10.18632/oncotarget.26455
|
| 37042-37053 |
|
| Metformin alters H2AZ dynamics and regulates androgen dependent prostate cancer progression |
|
https://doi.org/10.18632/oncotarget.26457
|
| 37054-37068 |
Reviews
|
| Radioresistance of cancer cells integrin αvβ3 and thyroid hormone |
|
https://doi.org/10.18632/oncotarget.26434
|
| 37069-37075 |
Corrections
|
| Correction: BNIP3 modulates the interface between B16F10 melanoma cells and immune cells |
|
https://doi.org/10.18632/oncotarget.26474
|
| 37076-37076 |
|
| Correction: PDL1 expression heterogeneity in nonsmall cell lung cancer: evaluation of small biopsies reliability |
|
https://doi.org/10.18632/oncotarget.26475
|
| 37077-37077 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
